article thumbnail

Corporations: “get healthcare costs under control”

World of DTC Marketing

SUMMARY: A new survey from the Kaiser Family Foundation and the Purchaser Business Group on Health shows signs that corporate executives might be warming to the idea of government getting more involved to rein in the excesses of the healthcare system. It’s affecting their bottom lines, and they won’t stand for that.

article thumbnail

The rise of prescription drug abuse and drug diversion

pharmaphorum

As prescription drug abuse has grown in the US and Europe, the diversion of such treatments from legitimate sources has also increased. Drug diversion is the channelling of prescription drugs from a medical source into the illegal market. Why drug diversion represents a challenge.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

What do future healthcare CEOs look like?

World of DTC Marketing

American healthcare is in trouble. I have to laugh when I hear that a pharma company is patient-centric because that’s become a slogan to make employees feel good about themselves while the costs of prescription drugs increase every year. Highest-paid CEOs in 2019: Who made the list from healthcare. This has to end.

article thumbnail

How retailers and “payviders” are disrupting U.S. healthcare in 2024

Clarivate

Strategy #1: innovate and create Amazon founder Jeff Bezos has said that overnight success takes about 10 years — and that ramp-up period may be what’s playing out for the ecommerce giant in healthcare. billion, following an earlier failed healthcare venture with Berkshire Hathaway and JPMorgan Chase.

Retail 52
article thumbnail

ELITE 2023 Sales MVP Laura Blair of ConnectiveRx

PM360

After a developmental day of shadowing a pharma sales rep, the fire was lite and she joined the sales team never looking back, ultimately landing her a role at ConnectiveRx in 2010. Interestingly, her approach was not only shaped by professional aptitude. I can see how that’s honed her dialog with clients in a standout way.

Sales 94
article thumbnail

Navigating the Challenges of Biopharma Product Launches: A Blueprint for Success

PM360

The landscape is highly competitive with new prescription medications launching worldwide each year. Key stumbling blocks include payer activation and reimbursement hurdles, regulatory complexities, tepid market adoption by healthcare professionals (HCPs), field force inefficiencies, and obstacles in engaging and adopting patients.

article thumbnail

Breaking through the forecasting fog – 3 trends that will impact critical medicine supply in 2023

pharmaphorum

Demand has also increased due to changes in prescribing protocols, leading to a higher underlying number of prescriptions for certain antibiotic medicines. We are now facing a similar moment in healthcare policy, driven by the combination in rapid succession of the pandemic impact and the war in Ukraine, including the ongoing energy crisis.